$0.70 0.00 (-0.03%)
11/24/2009 4:00 PM

MiddleBrook Pharmaceuticals, Inc. (MBRK)

CAPS Rating: 3 out of 5

A pharmaceutical company focused on developing and commercializing anti-infective drug products that fulfill substantial unmet medical needs in the treatment of infectious disease.

Featured Broker Partners